249 related articles for article (PubMed ID: 28366868)
21. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
[TBL] [Abstract][Full Text] [Related]
22. Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
Inderbinen SG; Zogg M; Kley M; Smieško M; Odermatt A
Toxicol Appl Pharmacol; 2021 Feb; 412():115387. PubMed ID: 33387577
[TBL] [Abstract][Full Text] [Related]
23. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
24. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
Hatakeyama H; Inaba S; Miyamori I
Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
[TBL] [Abstract][Full Text] [Related]
25. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
Draper N; Stewart PM
J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
[TBL] [Abstract][Full Text] [Related]
26. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
27. The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.
Krozowski Z; Li KX; Koyama K; Smith RE; Obeyesekere VR; Stein-Oakley A; Sasano H; Coulter C; Cole T; Sheppard KE
J Steroid Biochem Mol Biol; 1999; 69(1-6):391-401. PubMed ID: 10419017
[TBL] [Abstract][Full Text] [Related]
28. Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation.
Rabbitt EH; Lavery GG; Walker EA; Cooper MS; Stewart PM; Hewison M
FASEB J; 2002 Jan; 16(1):36-44. PubMed ID: 11772934
[TBL] [Abstract][Full Text] [Related]
29. Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity.
Mazzocchi G; Aragona F; Malendowicz LK; Gottardo L; Nussdorfer GG
J Investig Med; 2001 Mar; 49(2):191-4. PubMed ID: 11288760
[TBL] [Abstract][Full Text] [Related]
30. The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity.
Nakata T; Fujita A; Umeda M; Yoshida H; Inami K; Masuzaki H; Sawai H
Springerplus; 2016; 5():40. PubMed ID: 26835222
[TBL] [Abstract][Full Text] [Related]
31. Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.
Patel P; Hardy R; Sumathi V; Bartle G; Kindblom LG; Grimer R; Bujalska I; Stewart PM; Rabbitt E; Gittoes NJ; Cooper MS
Endocr Relat Cancer; 2012 Aug; 19(4):589-98. PubMed ID: 22719058
[TBL] [Abstract][Full Text] [Related]
32. Role of human chorionic gonadotropin in maintaining 11beta-hydroxysteroid dehydrogenase type 2 expression in human placental syncytiotrophoblasts.
Ni XT; Duan T; Yang Z; Guo CM; Li JN; Sun K
Placenta; 2009 Dec; 30(12):1023-8. PubMed ID: 19880179
[TBL] [Abstract][Full Text] [Related]
33. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
Latif SA; Pardo HA; Hardy MP; Morris DJ
Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors.
Lanz B; Kadereit B; Ernst S; Shojaati K; Causevic M; Frey BM; Frey FJ; Mohaupt MG
Kidney Int; 2003 Sep; 64(3):970-7. PubMed ID: 12911547
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
[TBL] [Abstract][Full Text] [Related]
36. Local cortisol/corticosterone activation in skin physiology and pathology.
Terao M; Katayama I
J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
[TBL] [Abstract][Full Text] [Related]
37. Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11beta-hydroxysteroid dehydrogenase 2.
Kim CH; Cho YS
Cell Biochem Funct; 2010 Aug; 28(6):440-7. PubMed ID: 20629036
[TBL] [Abstract][Full Text] [Related]
38. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
39. Taxifolin inhibits rat and human 11β-hydroxysteroid dehydrogenase 2.
Wu C; Cao S; Hong T; Dong Y; Li C; Wang Q; Sun J; Ge RS
Fitoterapia; 2017 Sep; 121():112-117. PubMed ID: 28709706
[TBL] [Abstract][Full Text] [Related]
40. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2.
Gong R; Morris DJ; Brem AS
Life Sci; 2008 Mar; 82(11-12):631-7. PubMed ID: 18261751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
